Aurinia Pharmaceuticals Inc (AUPH)

[Churchill54]

Just to review, from the conference call: Benlysta is no competition, pricing for Voc may be at the high end of expectations, the label should support IP 2037, the company may be acquired but not given away, expect partnerships for non US sales. I expect a 4-6 billion buyout in 2021 which is 30-45. That’s worth the daily bs manipulation which I expect to continue until and maybe beyond approval. I don’t think we see single digits once we are approved but that’s a possibility before approval. I am in this for the buyout and wouldn’t consider selling under 30 which isn’t likely to happen without a buyout. Auph is a great buy now with a minimal amount of risk. Don’t be discouraged by the resident jerk who lives to add angst on every downturn. He was wrong on Ariad and will be wrong here as well, a total loser.